These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37866094)

  • 1. Molecular point-of-care devices for the diagnosis of infectious diseases in resource-limited settings - A review of the current landscape, technical challenges, and clinical impact.
    Gavina K; Franco LC; Khan H; Lavik JP; Relich RF
    J Clin Virol; 2023 Dec; 169():105613. PubMed ID: 37866094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in addressing technical challenges of point-of-care diagnostics in resource-limited settings.
    Wang S; Lifson MA; Inci F; Liang LG; Sheng YF; Demirci U
    Expert Rev Mol Diagn; 2016; 16(4):449-59. PubMed ID: 26777725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sexually Transmitted Infection Point-of-Care Testing in Resource-Limited Settings: A Narrative Review Guided by an Implementation Framework.
    Chitneni P; Owembabazi M; Muyindike W; Asiimwe S; Masete G; Mbalibulha Y; Nakku-Joloba E; Manabe YC; Haberer JE; Matthews LT; Van Der Pol B
    Sex Transm Dis; 2023 Oct; 50(10):e11-e16. PubMed ID: 37433000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Point-of-Care Assay Development: Design and Considerations.
    Hassman A; Rouchka C; Sunino D; Espinal FV; Youssef M; Casey RR
    Curr Protoc; 2024 Jun; 4(6):e1058. PubMed ID: 38884351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point of Care Diagnostics in Resource-Limited Settings: A Review of the Present and Future of PoC in Its Most Needed Environment.
    Heidt B; Siqueira WF; Eersels K; Diliën H; van Grinsven B; Fujiwara RT; Cleij TJ
    Biosensors (Basel); 2020 Sep; 10(10):. PubMed ID: 32987809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Point-of-Care Testing for Infectious Diseases: Past, Present, and Future.
    Kozel TR; Burnham-Marusich AR
    J Clin Microbiol; 2017 Aug; 55(8):2313-2320. PubMed ID: 28539345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Point-of-care testing for sexually transmitted infections in low-resource settings.
    Vargas S; Calvo G; Qquellon J; Vasquez F; Blondeel K; Ballard R; Toskin I
    Clin Microbiol Infect; 2022 Jul; 28(7):946-951. PubMed ID: 34118424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smartphones as mobile microbiological laboratories.
    Ong DSY; Poljak M
    Clin Microbiol Infect; 2020 Apr; 26(4):421-424. PubMed ID: 31610301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Point of Care Diagnostics for HIV in Resource Limited Settings: An Overview.
    Manoto SL; Lugongolo M; Govender U; Mthunzi-Kufa P
    Medicina (Kaunas); 2018 Mar; 54(1):. PubMed ID: 30344234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging technologies in point-of-care molecular diagnostics for resource-limited settings.
    Peeling RW; McNerney R
    Expert Rev Mol Diagn; 2014 Jun; 14(5):525-34. PubMed ID: 24784765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in point-of-care nucleic acid extraction technologies for rapid diagnosis of human and plant diseases.
    Paul R; Ostermann E; Wei Q
    Biosens Bioelectron; 2020 Dec; 169():112592. PubMed ID: 32942143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comparison of Optical, Electrochemical, Magnetic, and Colorimetric Point-of-Care Biosensors for Infectious Disease Diagnosis.
    Pashchenko O; Shelby T; Banerjee T; Santra S
    ACS Infect Dis; 2018 Aug; 4(8):1162-1178. PubMed ID: 29860830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostics in a digital age: an opportunity to strengthen health systems and improve health outcomes.
    Peeling RW
    Int Health; 2015 Nov; 7(6):384-9. PubMed ID: 26553825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current state of commercial point-of-care nucleic acid tests for infectious diseases.
    Zhang JY; Bender AT; Boyle DS; Drain PK; Posner JD
    Analyst; 2021 Apr; 146(8):2449-2462. PubMed ID: 33899053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infectious pathogens meet point-of-care diagnostics.
    Zarei M
    Biosens Bioelectron; 2018 May; 106():193-203. PubMed ID: 29428589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical and economic impact of point-of-care CD4 testing in mozambique and other resource-limited settings: a cost-effectiveness analysis.
    Hyle EP; Jani IV; Lehe J; Su AE; Wood R; Quevedo J; Losina E; Bassett IV; Pei PP; Paltiel AD; Resch S; Freedberg KA; Peter T; Walensky RP
    PLoS Med; 2014 Sep; 11(9):e1001725. PubMed ID: 25225800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Point-of-care testing for infectious diseases: opportunities, barriers, and considerations in community pharmacy.
    Gubbins PO; Klepser ME; Dering-Anderson AM; Bauer KA; Darin KM; Klepser S; Matthias KR; Scarsi K
    J Am Pharm Assoc (2003); 2014; 54(2):163-71. PubMed ID: 24632931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Point-of-Care Laboratory in Clinical Microbiology.
    Drancourt M; Michel-Lepage A; Boyer S; Raoult D
    Clin Microbiol Rev; 2016 Jul; 29(3):429-47. PubMed ID: 27029593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Point-of-Care International Normalized Ratio (INR) Monitoring Devices for Patients on Long-term Oral Anticoagulation Therapy: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(12):1-114. PubMed ID: 23074516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point-of-care tests detecting HIV nucleic acids for diagnosis of HIV-1 or HIV-2 infection in infants and children aged 18 months or less.
    Ochodo EA; Guleid F; Deeks JJ; Mallett S
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD013207. PubMed ID: 34383961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.